# Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

> **NCT06954259** · — · ACTIVE_NOT_RECRUITING · sponsor: **Qiang Xu** · enrollment: 272 (actual)

## Conditions studied

- NSCLC (Advanced Non-small Cell Lung Cancer)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06954259
- **Lead sponsor:** Qiang Xu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06954259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06954259, "Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06954259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*